PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

VERTEX PHARMACEUTICALS INCORPORATED

MA · US

pharmaceuticals

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$11,300,000

Connections

13

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$16.7M
MMMMedicare/Medicaid
$15.8M
TAXTaxation/Internal Revenue Code
$13.3M
BUDBudget/Appropriations
$12.0M
TRDTrade
$6.0M
PHAPharmacy
$4.6M
VETVeterans
$3.5M
DEFDefense
$2.3M
DOCDistrict of Columbia
$1.2M
MEDMedical/Disease Research
$440K

Lobbying Firms Retained

VERTEX PHARMACEUTICALS INCORPORATED$12.2M
TARPLIN, DOWNS & YOUNG, LLC$1.5M
AVENUE SOLUTIONS$740K
STANTON PARK GROUP$700K
EMPIRE CONSULTING GROUP$650K
CGCN GROUP, LLC$420K
CROSSROADS STRATEGIES, LLC$390K
MARSHALL & POPP, LLC$340K
MCLARTY INBOUND LLC$200K
HOLLAND & KNIGHT LLP$130K
CAPITOL COUNSEL LLC$100K
ALSTON & BIRD LLP$70K
WILLIAMS AND JENSEN, PLLC$50K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
commented_onCenters for Medicare & Medicaid ServicesPublic comment on CMS-2023-0115: Medicare Program: Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018–2022Source
Employed byCAPITOL COUNSEL LLCHired CAPITOL COUNSEL LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byWILLIAMS AND JENSEN, PLLCHired WILLIAMS AND JENSEN, PLLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byEMPIRE CONSULTING GROUPHired EMPIRE CONSULTING GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed bySTANTON PARK GROUPHired STANTON PARK GROUP to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byTARPLIN, DOWNS & YOUNG, LLCHired TARPLIN, DOWNS & YOUNG, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023)Source
Employed byCROSSROADS STRATEGIES, LLCHired CROSSROADS STRATEGIES, LLC to lobby (2nd Quarter (Apr 1 - June 30) 2023)Source
Employed byAVENUE SOLUTIONSHired AVENUE SOLUTIONS to lobby (2nd Quarter (Apr 1 - June 30) 2023)Source
Employed byCGCN GROUP, LLCHired CGCN GROUP, LLC to lobby (4th Quarter (Oct 1 - Dec 31) 2024)Source
Employed byHOLLAND & KNIGHT LLPHired HOLLAND & KNIGHT LLP to lobby (4th Quarter (Oct 1 - Dec 31) 2024)Source
Employed byMARSHALL & POPP, LLCHired MARSHALL & POPP, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025)Source
Employed byMCLARTY INBOUND LLCHired MCLARTY INBOUND LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2025)Source
Employed byALSTON & BIRD LLPHired ALSTON & BIRD LLP to lobby (1st Quarter (Jan 1 - Mar 31) 2026)Source